Aswin K Mohan: HLA Beyond Histocompatibility – Redefining Immune Recognition in Modern Medicine
Aswin K Mohan, Medicine Specialist at AIIMS Bibinagar, shared a post on LinkedIn about the recent article she and her colleagues co-authored,published in Frontiers in Immunology adding:
“We often think of HLA as a matching problem.
But HLA is much more than matching.
It is fundamentally a system of immune recognition – influencing how the immune system sees peptides, responds to transfused cells, recognises transplanted organs, reacts to drugs, controls infections, and even identifies cancer cells.
And that broader perspective matters.
I’m delighted to share our new review, ‘Beyond Histocompatibility: Human Leukocyte Antigen as a Cross-Disciplinary Platform for Immune Recognition and Clinical Decision-Making,’ published in Frontiers in Immunology.
I’m grateful to Saikat Mandal, Joyisa Deb, Suhasini Sil, Manideepa Maji, Shirin Hasan, Fahad Hassan Ashraf and Arkadeep Dhali for bringing together perspectives from different disciplines and making this collaboration possible.
A special thank you to our reviewers and the Frontiers in Immunology editorial team for their thoughtful input throughout the process.
For me, this review was a reminder that HLA sits at a fascinating intersection of immunology, transfusion medicine, genetics and clinical decision-making.”
Title: Beyond histocompatibility: human leukocyte antigen as a cross-disciplinary platform for immune recognition and clinical decision-making
Authors: Saikat Mandal, Joyisa Deb, Aswin K. Mohan, Suhasini Sil, Manideepa Maji, Shirin Hasan, Fahad Hassan Ashraf, Arkadeep Dhali
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 25, 2026, 19:55Giacomo Buso: LIPLEG Provides the Strongest Evidence to Date on Lipedema Treatment
-
Oct 25, 2026, 19:54Nicholas Lee: ASH Program Connects Trainees and Faculty With Mentors for Career Development
-
Oct 25, 2026, 19:53World Thrombosis Day Raises Blood Clot Awareness at Italian Airports
-
Oct 25, 2026, 19:49Tahsim Anwar: A Six-Year Analysis of Adverse Events in Therapeutic Apheresis
-
Oct 25, 2026, 19:37William Wallace: More than 1 in 3 People with Parkinson’s Were Low in B6
-
Oct 25, 2026, 19:36Andrés Felipe Escobar González: Individualized Treatment Strategies for HMB in BDUC
-
Oct 25, 2026, 19:34Christophe Nougier: Returning to Burundi for the WFH-Supported Twinning Project
-
Oct 25, 2026, 19:29Bogda Koczwara: Pre-Existing and New CVD in Patients With Cancer Are Associated With Higher Mortality
-
Oct 25, 2026, 19:23Özlem Turan: Advancing Care for Women and Girls With Bleeding Disorders at the European Parliament